You see, this is the type of post which doesn’t sit well with me. How is the current market cap irrelevant? If it’s a sham today, it’s a sham down the road... You guys are giving Gerald a pass and it really is a terrible thing. EMOR’s revs/cash cannot support an emerging biotech company and it’s obvious. They will never, at the current rate, be able to pay ambs, what they have agreed to
(1)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links